Table 2

Linear trend test of NIC for recanalisation and functional outcome

MedianCasesNo. of eventsUnivariable analysisMultivariable analysis
OR (95% CI)P valueOR (95% CI)P value
For successful recanalisation (AOL 2–3)†
Tertiles
 Q1, low-level NIC (<0.126)0.1083614 (38.89 %)1.000 (Reference)1.000 (Reference)
 Q2, moderate-level NIC (0.126–0.163)0.1423625 (69.44%)3.571 (1.346, 9.475)0.011*2.936 (1.013, 8.511)0.047*
 Q3, high-level NIC (>0.163)0.2003631 (86.11%)9.743 (3.060, 31.020)<0.001**12.433 (3.329, 46.427)<0.001**
P for trend<0.001**<0.001**
For good functional outcome (90-day mRS, 0–2)‡
Tertiles
 Q1, low-level NIC (<0.126)0.108369 (25.00%)1.000 (Reference)1.000 (Reference)
 Q2, moderate-level NIC (0.126–0.163)0.1423619 (52.78%)3.353 (1.235, 9.102)0.018*5.209 (1.403, 19.339)0.014*
 Q3, high-level NIC (>0.163)0.2003625 (69.44%)6.818 (2.421, 19.201)<0.001**16.382 (3.694, 72.655)<0.001**
P for trend<0.001**<0.001**
  • P values in bold indicate statistical significance.

  • *p<0.05, **p<0.01.

  • †Adjusted for time from symptom onset to imaging and admission National Institutes of Health Stroke Scale (NIHSS) in multivariable analysis.

  • ‡Adjusted for admission NIHSS and collateral score in multivariable analysis.

  • AOL, arterial occlusive lesion; mRS, modified Rankin Scale; NIC, normalised iodine concentration.